APPLICATION
ANDA091308
TYPE
ANDA
ORIGINAL APPROVAL
2012-04-06
LATEST ACTION
2026-06-24
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
IMIQUIMODDiscontinued
IMIQUIMOD 5% · CREAM · TOPICAL
Approval history
2026-06-24Labeling · Supplement 2 · standardAP
2012-04-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.